New Stock News | English Silicon Intelligence updates Hong Kong stock listing application: A comprehensive analysis of financial and pipeline progress.

According to the Securities Times app, on November 11, 2025, the global AI pharmaceutical company Insilico Medicine once again updated its listing application documents on the Hong Kong Stock Exchange. Previously, the company had submitted listing applications in 2023 and 2024, but they expired due to the validity period of the documents. After submitting the latest prospectus on May 8, 2025, the company quickly updated the materials at the end of the six-month validity period, maintaining the active status of its listing application.